The study of pathogen resistance and antimicrobial use in dementia: Study design and methodology

Archives of Gerontology and Geriatrics

Volumn 56, Issue 1, 2013, Pages 16-22

  Mitchell, Susan L ^a,c   Shaffer, Michele L ^b   Kiely, Dan K ^a   Givens, Jane L ^a,c   D'Agata, Erika ^c  

^a Hebrew SeniorLife Institute for Aging Research   (United States)

^b PENN STATE COLLEGE OF MEDICINE   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Dementia; Infections; Methodology; Nursing home; Palliative care

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL INFECTION; CLINICAL DECISION MAKING; COHORT ANALYSIS; CONTROLLED STUDY; DEMENTIA; FEMALE; FOLLOW UP; HEALTH CARE FACILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; METHODOLOGY; NURSING HOME PATIENT; PALLIATIVE THERAPY; PRIORITY JOURNAL; PROSPECTIVE STUDY; STUDY DESIGN;

AGED; AGED, 80 AND OVER; ANTI-INFECTIVE AGENTS; BACTERIAL INFECTIONS; DEMENTIA; DRUG RESISTANCE, BACTERIAL; FEMALE; HOMES FOR THE AGED; HUMANS; MALE; NURSING HOMES; PROSPECTIVE STUDIES;

EID: 84869489951     PISSN: 01674943     EISSN: 18726976     Source Type: Journal    
DOI: 10.1016/j.archger.2012.08.001     Document Type: Article

References (45)

1. Ahronheim J.C., Morrison R.S., Baskin S.A., Morris J., Meier D.E. Treatment of the dying in the acute care hospital. Advanced dementia and metastatic cancer. Archives of Internal Medicine 1996, 156:2094-2100.
2. Albert M., Cohen C. The Test for Severe Impairment: An instrument for the assessment of patients with severe cognitive dysfunction. Journal of the American Geriatrics Society 1992, 40:449-453.
3. Barry M.J., Cherkin D.C., YuChiao C., Fowler F.J., Skates S. A randomized trial of a multimedia shared decision-making program for men facing a treatment decision for benign prostatic hypertrophy. Disease Management & Health Outcomes 1997, 1:5-14.
4. D'Agata E.M. Rapidly rising prevalence of nosocomial multidrug-resistant, Gram-negative bacilli: A 9-year surveillance study. Infection Control and Hospital Epidemiology 2004, 25:842-846.
5. D'Agata E., Mitchell S.L. Patterns of antimicrobial use among nursing home residents with advanced dementia. Archives of Internal Medicine 2008, 168:357-362.
6. D'Agata E., Venkataraman L., DeGirolami P., Samore M. Molecular epidemiology of acquisition of ceftazidime-resistant gram-negative bacilli in a nonoutbreak setting. Journal of Clinical Microbiology 1997, 35:2602-2605.
7. Hanson L.C., Carey T.S., Caprio A.J., Lee T.J., Ersek M., Garrett J., et al. Improving decision-making for feeding options in advanced dementia: A randomized, controlled trial. Journal of the American Geriatrics Society 2011, 59:2009-2016.
8. Identification of Bacteria and Yeast Approved guidelines. M35-A 2007, Clinical and Laboratory Standards Institute, Wayne, PA.
9. Jones S.R., Parker D.F., Liebow E.S., Kimbrough R.C., Frear R.S. Appropriateness of antibiotic therapy in long-term care facilities. American Journal of Medicine 1987, 83:499-502.
10. Laird N.M., Ware J.H. Random-effects models for longitudinal data. Biometrics 1982, 38:963-974.
11. Lee D.C., Barlas D., Ryan J.G., Ward M.F., Sama A.E., Farber B.F. Methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: Prevalence and predictors of colonization in patients presenting to the emergency department from nursing homes. Journal of the American Geriatrics Society 2002, 50:1463-1465.
12. Liang K.Y., Zeger S.L. Longitudinal data analysis using generalized linear models. Biometrika 1986, 73:13-22.
13. Little R.J.A., Rubin D.B. Statistical analysis with missing data 2002, John Wiley & Sons, New York. second ed.
14. Loeb M., Simor A.E., Landry L., Walter S., McArthur M., Duffy J., et al. Antibiotic use in Ontario facilities that provide chronic care. Journal of General Internal Medicine 2001, 16:376-383.
15. Loeb M., Moss L., Stiller A., Smith S., Russo R., Molloy D.W., et al. Colonization with multiresistant bacteria and quality of life in residents of long-term-care facilities. Infect Control Hosp Epidemiol. 2001, 22:67-68.
16. LTCFocUS.org: Long-term Care: Facts on Care in the US 2012. Available at (accessed 31.01.2011). http://ltcfocus.org/.
17. Luchins D.J., Hanrahan P. What is appropriate health care for end-stage dementia?. Journal of the American Geriatrics Society 1993, 41:25-30.
18. McCullagh P., Nelder J.A. Generalized linear models 1989, Chapman & Hal, London. second ed.
19. Meier D.E., Ahronheim J.C., Morris J., Baskin-Lyons S., Morrison R.S. High short-term mortality in hospitalized patients with advanced dementia: Lack of benefit of tube feeding. Archives of Internal Medicine 2001, 161:594-599.
20. Mitchell S.L., Kiely D.K., Hamel M.B. Dying with advanced dementia in the nursing home. Archives of Internal Medicine 2004, 164:321-326.
21. Mitchell S.L., Kiely D.K., Jones R.N., Prigerson H., Volicer L., Teno J.M. Advanced dementia research in the nursing home: The CASCADE study. Alzheimer Disease and Associated Disorders 2006, 20:166-175.
22. Mitchell S.L., Teno J.M., Kiely D.K., Shaffer M.L., Jones R.N., Prigerson H.G., et al. The clinical course of advanced dementia. New England Journal of Medicine 2009, 361:1529-1538.
23. Mitchell S.L., Miller S.C., Teno J.M., Kiely D.K., Davis R.B., Shaffer M.L. Prediction of 6-month survival of nursing home residents with advanced dementia using ADEPT vs hospice eligibility guidelines. Journal of the American Medical Association 2010, 304:1929-1935.
24. Mitchell S.L., Black B.S., Ersek E., Hanson L.C., Miller S.C., Sachs G.A., et al. Advanced dementia: State-of-the-art and priorities for the next decade. Annals of Internal Medicine 2012, 156:45-51.
25. Mody L., Bradley S.F., Strausbaugh L.J., Muder R.R. Prevalence of ceftriaxone- and ceftazidime-resistant gram-negative bacteria in long-term-care facilities. Infection Control and Hospital Epidemiology 2001, 22:193-194.
26. Morrison R.S., Siu A.L. Survival in end-stage dementia following acute illness. Journal of the American Medical Association 2000, 284:47-52.
27. National Center for Health Statistics, National Vital Statistics Reports. 2011. (accessed 6.07.2011). http://www.cdc.gov/nchs/data/nvsr/nvsr59/nvsr59_04.pdf.
28. Nursing Home Compare, US Department of Health and Human Service, Centers for Medicare and Medicaid Services. Available at /(accessed 31.01.2012).
29. O'Fallon E., Pop-Vicas A., D'Agata E. The emerging threat of multidrug-resistant gram-negative organisms in long-term care facilities. Journals of Gerontology. Series A, Biological Sciences and Medical Sciences 2009, 64:138-141.
30. O'Fallon E., Schreiber R., Kandel R., D'Agata E.M. Multidrug-resistant gram-negative bacteria at a long-term care facility: Assessment of residents, healthcare workers, and inanimate surfaces. Infection Control and Hospital Epidemiology 2009, 30:1172-1179.
31. O'Fallon E., Kandel R., Schreiber R., D'Agata E.M. Acquisition of multidrug-resistant gram-negative bacteria: Incidence and risk factors within a long-term care population. Infection Control and Hospital Epidemiology 2010, 31:1148-1153.
32. Pickering T.D., Gurwitz J.H., Zaleznik D., Noonan J.P., Avorn J. The appropriateness of oral fluoroquinolone-prescribing in the long-term care setting. Journal of the American Geriatrics Society 1994, 42:28-32.
33. Pop-Vicas A.E., D'Agata E.M. The rising influx of multidrug-resistant gram-negative bacilli into a tertiary care hospital. Clinical Infectious Diseases 2005, 40:1792-1798.
34. Pop-Vicas A., Mitchell S.L., Kandel R., Schreiber R., D'Agata E.M. Multidrug-resistant gram-negative bacteria in a long-term care facility: Prevalence and risk factors. Journal of the American Geriatrics Society 2008, 56:1276-1280.
35. Performance standards for antimicrobial disk susceptibility tests. (2006). Wayne, PA: Clinical and Laboratory Standards Institute.
36. Reisberg B., Ferris S.H., de Leon M.J., Crook T. The global deterioration scale for assessment of primary degenerative dementia. American Journal of Psychiatry 1982, 139:1136-1139.
37. Sachs G.A., Shega J.W., Cox-Hayley D. Barriers to excellent end-of-life care for patients with dementia. Journal of General Internal Medicine 2004, 19:1057-1063.
38. Tenover F.C., Arbeit R.D., Goering R.V., Mickelsen P.A., Murray B.E., Persing D.H., et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. Journal of Clinical Microbiology 1995, 33:2233-2239.
39. Toubes E., Singh K., Yin D., Lyu R., Glick N., Russell L., et al. Risk factors for antibiotic-resistant infection and treatment outcomes among hospitalized patients transferred from long-term care facilities: does antimicrobial choice make a difference?. Clinical Infectious Diseases 2003, 36:724-730.
40. Trick W.E., Weinstein R.A., DeMarais P.L., Kuehnert M.J., Tomaska W., Nathan C., et al. Colonization of skilled-care facility residents with antimicrobial-resistant pathogens. Journal of the American Geriatrics Society 2001, 49:270-276.
41. Volicer L., Hurley A.C., Lathi D.C., Kowall N.W. Measurement of severity in advanced Alzheimer's disease. Journal of Gerontology 1994, 49:M223-M226.
42. Warren J.W., Palumbo F.B., Fitterman L., Speedie S.M. Incidence and characteristics of antibiotic use in aged nursing home patients. Journal of the American Geriatrics Society 1991, 39:963-972.
43. Yoshikawa T.T. Antimicrobial resistance and aging: Beginning of the end of the antibiotic era?. Journal of the American Geriatrics Society 2002, 50:S226-S229.
44. Yoshikawa T.T. Resistant pathogens: Considerations in geriatrics and infectious disease. Journal of the American Geriatrics Society 2002, 50:S225.
45. Zimmer J.G., Bentley D.W., Valenti W.M., Watson N.M. Systemic antibiotic use in nursing homes. A quality assessment. Journal of the American Geriatrics Society 1986, 34:703-710.